Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
8.8M
-
Shares change
-
+481K
-
Total reported value, excl. options
-
$96.8M
-
Value change
-
+$5.63M
-
Number of buys
-
21
-
Number of sells
-
-7
-
Price
-
$10.81
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2019
41 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q1 2019.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.8M shares
of 92.4M outstanding shares and own 9.52% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.41M shares), ORBIMED ADVISORS LLC (1.48M shares), Fosun International Ltd (794K shares), FMR LLC (622K shares), BlackRock Inc. (484K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (447K shares), VANGUARD GROUP INC (431K shares), GILDER GAGNON HOWE & CO LLC (234K shares), Point72 Asset Management, L.P. (147K shares), and CONNING INC. (129K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.